Nasus Pharma Ltd (NSRX) reporting calendar
Nasus Pharma Ltd files periodic reports with the SEC as NSRX on NYSE. Atlas tracks 1 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 25 Mar 2026
- Reports on record
- 1
Open NSRX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll NYSE reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 25 Mar 2026 | 84 days | 0001493152-26-012559 |
Source: SEC EDGAR company submissions for CIK 0002029039. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.